Iressa proves just as effective as chemotherapy for lung cancer
Friday, November 21, 2008 - 09:00
in Health & Medicine
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Centre...
Read the whole article on Science Centric
More from Science Centric
Related
- Iressa proves just as effective as chemotherapy for lung cancerThu, 20 Nov 2008, 19:32:03 EST
- Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapyFri, 16 May 2008, 11:22:13 EDT
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Proton therapy may reduce serious side effect of lung cancer treatmentThu, 13 Nov 2008, 10:51:08 EST
- Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancerThu, 13 Nov 2008, 15:22:04 EST